Answer
Katalin Karikó served as CEO of RNARx from 2006 to 2013. During her time at RNARx, she developed a technique for delivering RNA into cells, which has been used to develop a number of new drugs. She is now a professor at the University of Pennsylvania and continues to work on developing new RNA-based therapies.